| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 5.02T | 4.75T | 4.40T | 3.98T | 3.11T |
| Gross Profit | 1.68T | 1.63T | 1.51T | 1.33T | 1.06T |
| EBITDA | 691.20B | 665.14B | 645.76B | 575.90B | 484.94B |
| Net Income | 275.23B | 264.76B | 260.31B | 257.75B | 217.71B |
Balance Sheet | |||||
| Total Assets | 5.81T | 5.13T | 4.88T | 4.30T | 3.82T |
| Cash, Cash Equivalents and Short-Term Investments | 933.48B | 802.66B | 737.96B | 617.66B | 817.62B |
| Total Debt | 1.09T | 986.90B | 968.18B | 887.68B | 824.81B |
| Total Liabilities | 2.49T | 2.27T | 2.19T | 2.02T | 1.82T |
| Stockholders Equity | 3.25T | 2.81T | 2.64T | 2.24T | 1.97T |
Cash Flow | |||||
| Free Cash Flow | 256.77B | 268.46B | 156.93B | -16.18B | 130.97B |
| Operating Cash Flow | 465.85B | 514.45B | 399.57B | 158.90B | 245.07B |
| Investing Cash Flow | -317.82B | -322.29B | -226.72B | -224.19B | -180.79B |
| Financing Cash Flow | -160.79B | -168.58B | -130.09B | -118.69B | -48.70B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥6.63T | 25.26 | 9.46% | 1.52% | 5.53% | 3.94% | |
72 Outperform | ¥271.10B | 17.78 | 8.53% | 2.45% | 3.59% | 44.73% | |
69 Neutral | ¥628.04B | 16.11 | ― | 2.13% | 11.07% | 37.42% | |
67 Neutral | ¥1.16T | 33.90 | 0.85% | 2.36% | 1.79% | 239.72% | |
67 Neutral | ¥94.39B | 15.77 | 2.57% | 3.57% | -1.80% | 16.84% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
56 Neutral | ¥481.43B | 60.37 | 1.44% | 4.80% | 0.40% | 306.91% |